C3 and COVID-19: Since it has been reported that in severe and critical COVID-19 patients high anaphylatoxin serum levels were detected and because we found high antibody titers in patients that could potentially activate complement, we also investigated C3a and C5a plasma levels of patients with mild, severe and critical COVID-19.